✦ LIBER ✦

Is Tamoxifen Alone Adequate Therapy in Very Young Chinese Women with Operable Breast Cancer?

✍ Scribed by Hua Yang; Wei Ou; Haibo Sun; Qin Fang; Yaopan Wu; Si-yu Wang

Book ID: 109080275
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 112 KB
Volume: 18
Category: Article
ISSN: 1075-122X
DOI: 10.1111/j.1524-4741.2011.01202.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combination hormonal therapy with tamoxi

Combination hormonal therapy with tamoxifen plus fluoxymesterone versus tamoxifen alone in postmenopausal women with metastatic breast cancer. An updated analysis

✍ James N. Ingle; Harry J. Long; Donald I. Twito; Daniel J. Schaid; Stephen A. Cul 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 517 KB

Late follow-up of a randomized trial of

Late follow-up of a randomized trial of surgery plus tamoxifen versus tamoxifen alone in women aged over 70 years with operable breast cancer

✍ M. Fennessy; T. Bates; K. MacRae; D. Riley; J. Houghton; M. Baum 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

## Abstract ## Background Breast cancer has been considered a more indolent disease in the elderly, who are less tolerant of aggressive therapy. This trial tested the hypothesis that tamoxifen without surgery would provide adequate control of breast cancer for the remainder of life in elderly wome

A controlled trial of adjuvant tamoxifen

A controlled trial of adjuvant tamoxifen, with or without prednisolone, in post-menopausal women with operable breast cancer

✍ Fentiman, IS; Howell, A; Hamed, H; Lee, SM; Ranson, M; Wall, J; Chaudary, MA; As 📂 Article 📅 1994 🏛 Nature Publishing Group 🌐 English ⚖ 519 KB

Pharmacoeconomic analysis of adjuvant th

Pharmacoeconomic analysis of adjuvant therapy with exemestane, anastrozole, letrozole or tamoxifen in postmenopausal women with operable and estrogen receptor-positive breast cancer

✍ Juan Miguel Gil; Carlos Rubio-Terrés; Almudena del Castillo; Paloma González; Fe 📂 Article 📅 2006 🏛 Springer Milan 🌐 Spanish ⚖ 827 KB

Comparison of anastrozole versus tamoxif

Comparison of anastrozole versus tamoxifen as preoperative therapy in postmenopausal women with hormone receptor-positive breast cancer : The pre-operative “Arimidex” compared to Tamoxifen (PROACT) trial

✍ Luigi Cataliotti; Aman U. Buzdar; Shinzaburo Noguchi; Jose Bines; Yuichi Takatsu 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 193 KB 👁 2 views

## Abstract ## BACKGROUND The Pre‐Operative “Arimidex” Compared to Tamoxifen (PROACT) study was a randomized, multicenter study comparing anastrozole with tamoxifen as a preoperative treatment of postmenopausal women with large, operable (T2/3, N0‐2, M0), or potentially operable (T4b, N0‐2, M0) br

Randomized trial of tamoxifen alone or c

Randomized trial of tamoxifen alone or combined with fluoxymesterone as adjuvant therapy in postmenopausal women with resected estrogen receptor positive breast cancer. North Central Cancer Treatment Group Trial 89-30-52

✍ James N. Ingle; Vera J. Suman; James A. Mailliard; John W. Kugler; James E. Kroo 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 197 KB